Related references
Note: Only part of the references are listed.Decitabine Induces Gene Derepression on Monosomic Chromosomes: In Vitro and In Vivo Effects in Adverse-Risk Cytogenetics AML
Gabriele Greve et al.
CANCER RESEARCH (2021)
Randomized Phase II Study of AllTrans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status
Heiko Becker et al.
BLOOD (2021)
Retinoids in hematology: a timely revival?
Marie-Claude Geoffroy et al.
BLOOD (2021)
What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms
Maria Teresa Voso et al.
BLOOD (2021)
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Julia Stomper et al.
LEUKEMIA (2021)
Repeat to gene expression ratios in leukemic blast cells can stratify risk prediction in acute myeloid leukemia
M. Onishi-Seebacher et al.
BMC MEDICAL GENOMICS (2021)
Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response
Marina Scheller et al.
NATURE CANCER (2021)
Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 x 2, Phase II Trial
Michael Luebbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axis
Yang Cao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells
Marco Bolis et al.
CANCERS (2020)
Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Eytan M. Stein et al.
BLOOD (2020)
SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine Demonstrates a High Complete Response Rate and a Rapid Onset of Response in RARA-Positive Newly Diagnosed Unfit Acute Myeloid Leukemia
Stephane De Botton et al.
BLOOD (2020)
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome
Julia Stomper et al.
HAEMATOLOGICA (2019)
Regulation of transposable elements by DNA modifications
Ozgen Deniz et al.
NATURE REVIEWS GENETICS (2019)
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation
Nadja Blagitko-Dorfs et al.
LEUKEMIA (2019)
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
Christian Flotho et al.
SEMINARS IN CANCER BIOLOGY (2018)
Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
Sebastian Klobuch et al.
FRONTIERS IN PHARMACOLOGY (2018)
Elevated fetal haemoglobin is a predictor of better outcome inMDS/AML patients receiving 5-aza-2-deoxycytidine (Decitabine)
Michael Luebbert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
David Brocks et al.
NATURE GENETICS (2017)
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
M. Ryan Corces et al.
NATURE METHODS (2017)
Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist
Michael R. McKeown et al.
CANCER DISCOVERY (2017)
Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
Krysta Mila Coyle et al.
SCIENTIFIC REPORTS (2017)
Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy
Nina Cabezas-Wallscheid et al.
CELL (2017)
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
David Roulois et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids
Ariel R. Topletz et al.
MOLECULAR PHARMACOLOGY (2015)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia
Rainer Claus et al.
LEUKEMIA RESEARCH (2013)
Low-level processing of Illumina Infinium DNA Methylation BeadArrays
Timothy J. Triche et al.
NUCLEIC ACIDS RESEARCH (2013)
Functional DNA demethylation is accompanied by chromatin accessibility
Kurinji Pandiyan et al.
NUCLEIC ACIDS RESEARCH (2013)
Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat
Nadja Blagitko-Dorfs et al.
PLOS ONE (2013)
p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs
Katerina I. Leonova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation
Sudipto Das et al.
CANCER RESEARCH (2010)
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation
Christian Britschgi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome
Andres O. Soriano et al.
BLOOD (2007)
Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression
Rainer Claus et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Effects of 5-aza-2 '-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells
Y Guo et al.
LEUKEMIA (2006)
Differentiation-dependent alterations in histone methylation and chromatin architecture at the inducible chicken lysozyme gene
P Lefevre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo
F Fazi et al.
ONCOGENE (2005)
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements -: art. no. e38
AS Yang et al.
NUCLEIC ACIDS RESEARCH (2004)
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
WY Chen et al.
CANCER CELL (2004)
Sensitization by 5-aza-2′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1α,25-dihydroxyvitamin D3
N Niitsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
